| GLP-1 opportunity: Ethical responsibility & legal risks in health & nutrition marketing |
|
|
|
| | | | GLP-1 drugs have completely changed the weight management market, and the supplement industry has evolved right along with it. But with opportunity comes responsibility.
We invite you to join our critical discussion on what types of GLP-1 supplements might face ethical and legal implications, and what business leaders and product developers need to know before entering this landscape.
During this one-hour session, industry experts will explore: Responsible advertising practices in the GLP-1 landscape Potential regulatory consequences of misleading claims Balancing profit opportunities with ethical principles Current trends in supplement marketing Legal considerations for supplement companies
Details: Duration: 1 hour Price: $50.00 USD
As supplement brands rush to capitalize on the GLP-1 trend, it's crucial to understand where marketing innovation ends, and regulatory risk begins. Don't miss this opportunity to gain valuable insights that could protect your business while maintaining ethical standards.
Register now to be part of this important industry conversation. | | | | Register | | In order to view this asset, you must first log in to your SupplySide Supplement Journal account. Don't have an account? Join the community by signing up here! | | Host: | | |
|
|
|
| Cassie Smith Senior editorial content director, Informa Markets, SupplySide |
|
|
|
| Dave Foreman, RPh President, Herbal Pharmacist Media LLC |
| Devon Gholam, PhD Vice president of science and innovation, Step Change Innovations |
|
|
|
| Rend Al-Mondhiry, JD Partner, Amin Wasserman Gurnani LLP |
| Katie Bond, JD Partner, Keller and Heckman LLP |
|
|
|
|
